查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386577

誘導性多功能幹細胞市場報告：2030 年趨勢、預測與競爭分析

Induced Pluripotent Stem Cell Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

誘導性多功能幹細胞的趨勢和預測

預計到 2030 年，全球誘導性多功能幹細胞市場將達到約 26 億美元，2024 年至 2030 年複合年成長率為 10.3%。市場的主要驅動力是癌症發生率上升、幹細胞研究財政投資不斷增加，以及誘導誘導性多功能幹細胞幹細胞（ESC）的眾多優勢。全球誘導性多功能幹細胞市場的未來前景廣闊，研究和學術機構、生物技術和製藥公司以及醫院和診所市場存在商機。

誘導性多功能幹細胞市場洞察

Lucintel 預測，由於慢性病在世界各地普遍存在，藥物開發和發現仍將是預測期內最大的部分。

由於對基於幹細胞的研究的強勁且具有成本效益的關注、經濟的擴張、醫療保健策略的改進以及對個體化治療前景的認知不斷增強，預計亞太地區將在預測期內經歷最快的成長。

本報告回答了 11 個關鍵問題：

  • Q.1. 區隔市場中最有前途和高成長的機會是什麼？
  • Q.2. 哪個產業將以更快的速度成長？為什麼？
  • Q.3.哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要課題和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去五年發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章執行摘要

第2章全球誘導性多功能幹細胞市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與課題

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球誘導性多功能幹細胞市場趨勢（2018-2023）與預測（2024-2030）
  • 依工作流程分類的全球誘導性多功能幹細胞市場
    • 重新程式設計
    • 細胞培養
    • 細胞表徵/分析
    • 工程
    • 其他
  • 全球誘導性多功能幹細胞市場（依應用）
    • 藥物研發發現和發現
    • 再生醫學
    • 毒理學研究
    • 其他
  • 以最終用途分類的全球誘導性多功能幹細胞市場
    • 研究/學術機構
    • 生技/製藥公司
    • 醫院/診所

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球誘導性多功能幹細胞市場依地區分類
  • 誘導性多功能幹細胞市場
  • 歐洲誘導性多功能幹細胞市場
  • 亞太誘導性多功能幹細胞市場
  • 其他地區的誘導性多功能幹細胞市場

第5章競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 依工作流程分類的全球誘導性多功能幹細胞市場成長機會
    • 全球誘導性多功能幹細胞市場成長機會（依應用）
    • 全球誘導性多功能幹細胞市場成長機會（依最終用途）
    • 全球誘導性多功能幹細胞市場成長機會（依地區）
  • 全球誘導性多功能幹細胞市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 全球誘導性多功能幹細胞市場的產能擴張
    • 全球誘導性多功能幹細胞市場的合併、收購和合資企業
    • 認證和許可

第7章主要企業概況

  • Lonza
  • Axol Bioscience
  • Evotec
  • Hitachi
  • REPROCELL
  • Merck
  • REPROCELLS
  • Fate Therapeutics
  • Thermo Fisher Scientific
  • StemCellsFactory III
簡介目錄

Induced Pluripotent Stem Cell Trends and Forecast

The future of the global induced pluripotent stem cell market looks promising with opportunities in the research & academic institute, biotechnology & pharmaceutical company, and hospital & clinic markets. The global induced pluripotent stem cell market is expected to reach an estimated $2.6 billion by 2030 with a CAGR of 10.3% from 2024 to 2030. The major drivers for this market are rising prevalence of cancer, amplified financial investments in stem cell research, and the numerous benefits of induced pluripotent stem cells (iPSCs) compared to embryonic stem cells (ESCs).

A more than 150-page report is developed to help in your business decisions.

Induced Pluripotent Stem Cell by Segment

The study includes a forecast for the global induced pluripotent stem cell by workflow, application, end use, and region.

Induced Pluripotent Stem Cell Market by Workflow [Shipment Analysis by Value from 2018 to 2030]:

  • Reprogramming
  • Cell Culture
  • Cell Characterization / Analysis
  • Engineering
  • Others

Induced Pluripotent Stem Cell Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Drug Development & Discovery
  • Regenerative Medicine
  • Toxicology Studies
  • Others

Induced Pluripotent Stem Cell Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Research & Academic Institutes
  • Biotechnology & Pharmaceutical Companies
  • Hospitals & Clinics

Induced Pluripotent Stem Cell Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Induced Pluripotent Stem Cell Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies induced pluripotent stem cell companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the induced pluripotent stem cell companies profiled in this report include-

  • Lonza
  • Axol Bioscience
  • Evotec
  • Hitachi
  • Reprocell
  • Merck
  • Reprocells
  • Fate Therapeutics
  • Thermo Fisher Scientific
  • Stemcellsfactory III

Induced Pluripotent Stem Cell Market Insights

Lucintel forecasts that drug development & discovery will remain the largest segment over the forecast period because the chronic illnesses are spreading throughout the world.

APAC is expected to witness fastest growth over the forecast period due to robust, cost-effective focus on stem cell-based research, the expansion of economies, improvements in healthcare strategies, and the increasing recognition of the promise of personalized treatments.

Features of the Global Induced Pluripotent Stem Cell Market

Market Size Estimates: Induced pluripotent stem cell market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Induced pluripotent stem cell market size by workflow, application, end use, and region in terms of value ($B).

Regional Analysis: Induced pluripotent stem cell market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different workflow, application, end use, and regions for the induced pluripotent stem cell market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the induced pluripotent stem cell market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the induced pluripotent stem cell market size?

Answer: The global induced pluripotent stem cell market is expected to reach an estimated $2.6 billion by 2030.

Q.2 What is the growth forecast for induced pluripotent stem cell market?

Answer: The global induced pluripotent stem cell market is expected to grow with a CAGR of 10.3% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the induced pluripotent stem cell market?

Answer: The major drivers for this market are rising prevalence of cancer, amplified financial investments in stem cell research, and the numerous benefits of induced pluripotent stem cells (iPSCs) compared to embryonic stem cells (ESCs).

Q4. What are the major segments for induced pluripotent stem cell market?

Answer: The future of the global induced pluripotent stem cell market looks promising with opportunities in the research & academic institute, biotechnology & pharmaceutical company, and hospital & clinic markets.

Q5. Who are the key induced pluripotent stem cell market companies?

Answer: Some of the key induced pluripotent stem cell companies are as follows:

  • Lonza
  • Axol Bioscience
  • Evotec
  • Hitachi
  • Reprocell
  • Merck
  • Reprocells
  • Fate Therapeutics
  • Thermo Fisher Scientific
  • Stemcellsfactory III

Q6. Which induced pluripotent stem cell market segment will be the largest in future?

Answer: Lucintel forecasts that drug development & discovery will remain the largest segment over the forecast period because the chronic illnesses are spreading throughout the world.

Q7. In induced pluripotent stem cell market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness fastest growth over the forecast period due to robust, cost-effective focus on stem cell-based research, the expansion of economies, improvements in healthcare strategies, and the increasing recognition of the promise of personalized treatments.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the induced pluripotent stem cell market by workflow (reprogramming, cell culture, cell characterization / analysis, engineering, and others), application (drug development & discovery, regenerative medicine, toxicology studies, and others), end use (research & academic institutes, biotechnology & pharmaceutical companies, and hospitals & clinics), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Induced Pluripotent Stem Cell Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Induced Pluripotent Stem Cell Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Induced Pluripotent Stem Cell Market by Workflow
    • 3.3.1: Reprogramming
    • 3.3.2: Cell Culture
    • 3.3.3: Cell Characterization / Analysis
    • 3.3.4: Engineering
    • 3.3.5: Others
  • 3.4: Global Induced Pluripotent Stem Cell Market by Application
    • 3.4.1: Drug Development & Discovery
    • 3.4.2: Regenerative Medicine
    • 3.4.3: Toxicology Studies
    • 3.4.4: Others
  • 3.5: Global Induced Pluripotent Stem Cell Market by End Use
    • 3.5.1: Research & Academic Institutes
    • 3.5.2: Biotechnology & Pharmaceutical Companies
    • 3.5.3: Hospitals & Clinics

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Induced Pluripotent Stem Cell Market by Region
  • 4.2: North American Induced Pluripotent Stem Cell Market
    • 4.2.1: North American Induced Pluripotent Stem Cell Market by Application: Drug Development & Discovery, Regenerative Medicine, Toxicology Studies, and Others
    • 4.2.2: North American Induced Pluripotent Stem Cell Market by End Use: Research & Academic Institutes, Biotechnology & Pharmaceutical Companies, and Hospitals & Clinics
  • 4.3: European Induced Pluripotent Stem Cell Market
    • 4.3.1: European Induced Pluripotent Stem Cell Market by Application: Drug Development & Discovery, Regenerative Medicine, Toxicology Studies, and Others
    • 4.3.2: European Induced Pluripotent Stem Cell Market by End Use: Research & Academic Institutes, Biotechnology & Pharmaceutical Companies, and Hospitals & Clinics
  • 4.4: APAC Induced Pluripotent Stem Cell Market
    • 4.4.1: APAC Induced Pluripotent Stem Cell Market by Application: Drug Development & Discovery, Regenerative Medicine, Toxicology Studies, and Others
    • 4.4.2: APAC Induced Pluripotent Stem Cell Market by End Use: Research & Academic Institutes, Biotechnology & Pharmaceutical Companies, and Hospitals & Clinics
  • 4.5: ROW Induced Pluripotent Stem Cell Market
    • 4.5.1: ROW Induced Pluripotent Stem Cell Market by Application: Drug Development & Discovery, Regenerative Medicine, Toxicology Studies, and Others
    • 4.5.2: ROW Induced Pluripotent Stem Cell Market by End Use: Research & Academic Institutes, Biotechnology & Pharmaceutical Companies, and Hospitals & Clinics

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Induced Pluripotent Stem Cell Market by Workflow
    • 6.1.2: Growth Opportunities for the Global Induced Pluripotent Stem Cell Market by Application
    • 6.1.3: Growth Opportunities for the Global Induced Pluripotent Stem Cell Market by End Use
    • 6.1.4: Growth Opportunities for the Global Induced Pluripotent Stem Cell Market by Region
  • 6.2: Emerging Trends in the Global Induced Pluripotent Stem Cell Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Induced Pluripotent Stem Cell Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Induced Pluripotent Stem Cell Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Lonza
  • 7.2: Axol Bioscience
  • 7.3: Evotec
  • 7.4: Hitachi
  • 7.5: REPROCELL
  • 7.6: Merck
  • 7.7: REPROCELLS
  • 7.8: Fate Therapeutics
  • 7.9: Thermo Fisher Scientific
  • 7.10: StemCellsFactory III